Vero Biotech Raises $30 Million To Accelerate Commercialization Of Its Innovative Tankless Inhaled Nitric Oxide Delivery System
Amount Raised
$30 Million
Round Type
Funding Round
AtlantaBiotechnologyHealthcareHealth CareInvestors
Description
VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, today announced the successful close of a $30 million financing with Petrichor, a leading healthcare-dedicated growth capital provider. The proceeds will support further development and commercialization of VERO Biotech's GENOSYL Delivery System (DS), a tankless inhaled nitric oxide (iNO) delivery system. The third generation of the GENOSYL DS was recently approved by the FDA and represents a breakthrough in iNO technology benefitting both providers and patients. Patrick Lally, Partner of Petrichor, has joined the VERO Biotech Board of Directors
Quick answer
Vero Biotech Inc. raised $30 Million in a Funding Round round, dated January 11, 2023. Investors: Patrick Lally, Partner Of Petrichor and Petrichor. Vero Biotech Inc. is based in Atlanta, Georgia, United States.
- How much did Vero Biotech Inc. raise?
- Vero Biotech Inc. raised $30 Million in a Funding Round round on January 11, 2023.
- Who invested in Vero Biotech Inc?
- Patrick Lally, Partner Of Petrichor and Petrichor are named as investors in this round.
- What does Vero Biotech Inc. do?
- Vero biotech is an emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with..
- Where is Vero Biotech Inc. based and how big is it?
- Vero Biotech Inc. is based in Atlanta, Georgia, United States.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Vero Biotech Inc. that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $62K (Pre-Seed) on February 23, 2023.
- ReAlta Life Sciences raised $12M on February 22, 2023.
- U.S. Renal Care raised $3.1M (Seed) on February 16, 2023.
- MOLECULAR WORLD HEALTH raised $5K (Pre-Seed) on February 9, 2023.
- Ostial Corporation raised $7.5M (Series C) on February 8, 2023.
- NeOnc Technologies raised $10M on February 8, 2023.
Who to call at Vero Biotech Inc., and when
A new round usually means Vero Biotech Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vero Biotech Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vero Biotech Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vero Biotech Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vero Biotech Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Vero Biotech Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.